SARS-CoV-2 Spike RBD Antibody [2196] (HRP) | 10-063

SARS-CoV-2 Spike RBD Antibody [2196] (HRP) | 10-063 | Gentaur UK, US & Europe Distribution

Host: N/A

Reactivity: Virus

Homology: N/A

Immunogen: Sequenced from human survivors of COVID-19 (SARS-CoV-2) . The spike RBD is expressed on the surface of SARS-CoV-2.

Research Area: Infectious Disease, COVID-19

Tested Application: E

Application: ELISA (Quality Tested by ProSci)

Specificiy: Anti-SARS-CoV-2 Spike RBD-HRP, clone 2196, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD) . This antibody does not cross-react with the N-terminal domain (NTD) of the spike protein or the RBD of SARS-CoV.

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: N/A

Clonality: Recombinant Monoclonal

Clone: 2196

Isotype: Human IgG1

Conjugate: HRP

Physical State: Liquid

Buffer: This HRP-conjugated antibody is formulated in 0.01 M phosphate buffered saline (PBS) pH 7.4, 1% BSA. (Warning: Use of sodium azide as a preservative will inhibit the enzyme activity of horseradish peroxidase)

Concentration: 0.5 mg/ml

Storage Condition: This horseradish peroxidase conjugated monoclonal antibody is stable when stored at 2-8˚ C. Do not freeze.

Alternate Name: SARS-CoV-2 Spike RBD Antibody, Receptor Binding Domain Monoclonal Antibody

User Note: 43470568

BACKGROUND: N/A